Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 14  •  04:00PM ET
0.3446
Dollar change
+0.0204
Percentage change
6.29
%
Index
-
P/E
-
EPS (ttm)
-0.28
Insider Own
81.93%
Shs Outstand
78.29M
Perf Week
4.11%
Market Cap
63.39M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
33.25M
Perf Month
-65.88%
Enterprise Value
52.00M
PEG
-
EPS next Q
-
Inst Own
0.13%
Perf Quarter
-91.03%
Income
-2.72M
P/S
2.36
EPS this Y
-
Inst Trans
-0.30%
Perf Half Y
-96.31%
Sales
26.85M
P/B
0.19
EPS next Y
-
ROA
-2.11%
Perf YTD
-90.66%
Book/sh
1.85
P/C
4.36
EPS next 5Y
-
ROE
-2.41%
52W High
17.17 -97.99%
Perf Year
-96.43%
Cash/sh
0.08
P/FCF
-
EPS past 3/5Y
- -
ROIC
-1.49%
52W Low
0.27 26.83%
Perf 3Y
-94.26%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-23.97% -11.45%
Gross Margin
15.23%
Volatility
16.01% 25.71%
Perf 5Y
-98.38%
Dividend TTM
-
EV/Sales
1.94
EPS Y/Y TTM
74.15%
Oper. Margin
-7.91%
ATR (14)
0.11
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.33
Sales Y/Y TTM
-10.12%
Profit Margin
-10.13%
RSI (14)
27.61
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
1.82
EPS Q/Q
-146.98%
SMA20
-29.24%
Beta
1.95
Target Price
-
Payout
-
Debt/Eq
0.01
Sales Q/Q
13.92%
SMA50
-62.13%
Rel Volume
0.40
Prev Close
0.32
Employees
-
LT Debt/Eq
0.00
Earnings
-
SMA200
-94.36%
Avg Volume
245.25K
Price
0.34
IPO
Jan 12, 2021
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
98,716
Change
6.29%
Feb-26-26 04:15PM
Oct-01-25 01:41PM
Jul-23-25 06:36AM
May-28-25 04:30PM
May-02-25 08:30AM
08:30AM Loading…
Apr-28-25 08:30AM
Apr-21-25 08:30AM
Mar-19-25 08:30AM
Feb-28-25 08:30AM
Feb-19-25 07:30AM
Dec-27-24 09:30AM
09:05AM
09:00AM
Dec-19-24 08:30AM
Nov-29-24 10:58AM
10:58AM Loading…
10:58AM
10:11AM
09:00AM
Nov-28-24 06:32AM
Nov-22-24 08:30AM
Oct-29-24 08:00AM
Aug-13-24 08:00AM
BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.